Cancer-specific survival | Overall survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI of HR | p-value | HR | 95% CI of HR | p-value | |
Entire cohorts | 2.162 | 1.221–3.829 | 0.008 | 2.013 | 1.206–3.361 | 0.007 |
Subgroups according to the tumor histology | ||||||
Clear cell histology | 2.312 | 1.274–4.193 | 0.006 | 2.204 | 1.279–3.799 | 0.004 |
Other histology | 0.767 | 0.076–7.771 | 0.822 | 0.285 | 0.043–1.879 | 0.192 |
Subgroups according to the Heng’s model | ||||||
Favorable risk | 1.556 | 0.487–4.967 | 0.455 | 1.767 | 0.602–5.185 | 0.300 |
Intermediate | 1.809 | 0.907–3.611 | 0.093 | 1.583 | 0.851–2.947 | 0.147 |
Poor | 1.538 | 0.339–6.972 | 0.577 | 1.735 | 0.406–7.416 | 0.457 |